Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Advances in Multi-Omics Study of Prognostic Biomarkers of Diffuse Large B-Cell Lymphoma

1 Jan 2022

Abstract excerpt

As the most common subtype of non-Hodgkin's lymphoma, diffuse large B-cell lymphoma (DLBCL) is characterized by a huge degree of clinical and prognostic heterogeneity. Currently, there is an urgent need for highly specific and sensitive biomarkers to predict the therapeutic response of DLBCL and assess which patients can benefit from systemic chemotherapy to help develop more precise therapeutic regimens for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Lymphoma Diagnosis and Treatment
Share to Single-cell and spatial transcriptomics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35280688
DOI: 10.7150/ijbs.67892

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Advances in Multi-Omics Study of Prognostic Biomarkers of Diffuse Large B-Cell LymphomaPMID 35280688Read ↗

Multi-omics dataset to decipher the complexity of drug resistance in diffuse large B-cell lymphomaSemantic proximity Read ↗

The crucial role of multiomic approach in cancer research and clinically relevant outcomesSemantic proximity Read ↗

Single‑cell multi‑omics advances in lymphoma research (Review)Semantic proximity Read ↗

A ferroptosis-related lncRNAs signature as a potential biomarker for diffuse large B-cell lymphoma patientsSemantic proximity Read ↗

Identification of a 16-MTGs Prognostic Signature in Diffuse large B-cell lymphomaSemantic proximity Read ↗

Single‐Cell Multi‐Omics and Its Prospective Application in Cancer BiologySemantic proximity Read ↗

Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signatureSemantic proximity Read ↗

Decoding the Heterogeneity of Diffuse Large B-Cell Lymphomas: A Comprehensive Genetic, Transcriptomic, and Phenotypic Profiling of B-Cell Lymphoma Cell Lines.Semantic proximity Read ↗

Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signatureSemantic proximity Read ↗

Molecular pathogenesis of diffuse large B-cell lymphoma.Semantic proximity Read ↗

Multiomics insights on the onset, progression, and metastatic evolution of breast cancerSemantic proximity Read ↗

Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agentsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.